Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
Clinical trial NCT02296190 · COMPLETED
Trial details
- NCT number
- NCT02296190
- Sponsor
- Milestone Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-27
- Primary completion
- 2016-12-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.